|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Monopar Therapeutics (NASDAQ: MNPR) through any online brokerage.
The latest price target for Monopar Therapeutics (NASDAQ: MNPR) was reported by Roth Capital on 2021-01-28. The analyst firm set a price target for 49.00 expecting MNPR to rise to within 12 months (a possible 822.79% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $5.31 last updated Fri Apr 16 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Monopar Therapeutics.
There is no upcoming split for Monopar Therapeutics.